Geode Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Sell
904,425
-3,536
-0.4% -$10.2K ﹤0.01% 3051
2025
Q1
$1.95M Buy
907,961
+21,547
+2% +$46.3K ﹤0.01% 3041
2024
Q4
$3.43M Sell
886,414
-14,848
-2% -$57.5K ﹤0.01% 2925
2024
Q3
$5.9M Sell
901,262
-237,861
-21% -$1.56M ﹤0.01% 2674
2024
Q2
$8.26M Buy
1,139,123
+269,740
+31% +$1.96M ﹤0.01% 2446
2024
Q1
$6.6M Buy
869,383
+221,665
+34% +$1.68M ﹤0.01% 2550
2023
Q4
$2.95M Buy
647,718
+31,412
+5% +$143K ﹤0.01% 2961
2023
Q3
$2.43M Buy
616,306
+79,746
+15% +$315K ﹤0.01% 3006
2023
Q2
$1.68M Buy
536,560
+264,596
+97% +$828K ﹤0.01% 3165
2023
Q1
$1.23M Buy
271,964
+41,173
+18% +$187K ﹤0.01% 3247
2022
Q4
$953K Buy
230,791
+116,901
+103% +$483K ﹤0.01% 3363
2022
Q3
$364K Hold
113,890
﹤0.01% 3898
2022
Q2
$223K Hold
113,890
﹤0.01% 4195
2022
Q1
$461K Hold
113,890
﹤0.01% 3972
2021
Q4
$1.23M Sell
113,890
-170
-0.1% -$1.83K ﹤0.01% 3606
2021
Q3
$1.32M Buy
114,060
+1,606
+1% +$18.5K ﹤0.01% 3541
2021
Q2
$1.1M Buy
112,454
+11,020
+11% +$108K ﹤0.01% 3541
2021
Q1
$1.48M Buy
101,434
+16,027
+19% +$234K ﹤0.01% 3397
2020
Q4
$1.83M Buy
85,407
+16,914
+25% +$362K ﹤0.01% 3132
2020
Q3
$1.04M Buy
68,493
+42,630
+165% +$647K ﹤0.01% 3195
2020
Q2
$332K Buy
25,863
+4,798
+23% +$61.6K ﹤0.01% 3507
2020
Q1
$194K Sell
21,065
-550
-3% -$5.07K ﹤0.01% 3563
2019
Q4
$287K Hold
21,615
﹤0.01% 3691
2019
Q3
$191K Sell
21,615
-47
-0.2% -$415 ﹤0.01% 3788
2019
Q2
$309K Sell
21,662
-15,432
-42% -$220K ﹤0.01% 3641
2019
Q1
$1.22M Buy
37,094
+2,012
+6% +$66.1K ﹤0.01% 3079
2018
Q4
$2.08M Buy
35,082
+1,853
+6% +$110K ﹤0.01% 2750
2018
Q3
$4.66M Buy
33,229
+16,517
+99% +$2.32M ﹤0.01% 2397
2018
Q2
$2.05M Buy
16,712
+5,267
+46% +$646K ﹤0.01% 2848
2018
Q1
$1.02M Buy
11,445
+1,905
+20% +$170K ﹤0.01% 3111
2017
Q4
$528K Sell
9,540
-332
-3% -$18.4K ﹤0.01% 3338
2017
Q3
$417K Sell
9,872
-78
-0.8% -$3.3K ﹤0.01% 3425
2017
Q2
$419K Sell
9,950
-3,547
-26% -$149K ﹤0.01% 3416
2017
Q1
$754K Buy
13,497
+1,506
+13% +$84.1K ﹤0.01% 3149
2016
Q4
$457K Buy
11,991
+367
+3% +$14K ﹤0.01% 3297
2016
Q3
$461K Buy
11,624
+8
+0.1% +$317 ﹤0.01% 3281
2016
Q2
$834K Buy
11,616
+937
+9% +$67.3K ﹤0.01% 2995
2016
Q1
$856 Buy
10,679
+997
+10% +$80 ﹤0.01% 2965
2015
Q4
$730K Sell
9,682
-203
-2% -$15.3K ﹤0.01% 3071
2015
Q3
$3.79M Buy
9,885
+2,294
+30% +$879K ﹤0.01% 2017
2015
Q2
$3.15M Buy
7,591
+738
+11% +$307K ﹤0.01% 2216
2015
Q1
$3.26M Buy
6,853
+3,757
+121% +$1.79M ﹤0.01% 2120
2014
Q4
$1.15M Buy
3,096
+2,000
+182% +$740K ﹤0.01% 2758
2014
Q3
$258K Buy
+1,096
New +$258K ﹤0.01% 3466